Posted on February 9th, 2012 by Health News
Researchers at the Rothman Institute at Jefferson examined data on patients being treated for lumbar stenosis and the degenerative spine condition spondylolisthesis and found that patients who received epidural steroid injections (ESI) had a higher rate of crossover to surgery and fared worse in physical health and bodily pain versus those who did not receive [...]
No Comments »
Filed under: Pharmacy News
Posted on February 9th, 2012 by Health News
Patients taking antidepressants up to three years prior to undergoing a total hip replacement (THR) were more likely to report greater pain before and after surgery and less satisfaction with their procedure, according to new research presented today at the 2012 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS).
No Comments »
Filed under: Pharmacy News
Posted on February 4th, 2012 by Health News
The California surgeons, who market gastric-banding surgery for weight loss through 1-800-Get-Thin ads, face FDA scrutiny, a state investigation into alleged billing fraud, a whistleblower suit, and more. Medscape Medical News
No Comments »
Filed under: General Health News
Posted on February 3rd, 2012 by Health News
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal [...]
No Comments »
Filed under: Pharmacy News
Posted on February 3rd, 2012 by Health News
Novartis announced today that following a priority review, the US Food and Drug Administration has approved an update to the Gleevec (imatinib mesylate) tablets label to recommend 36 months of treatment after surgery for adult patients with KIT (CD117)-positive gastrointestinal stromal tumors (GIST) who met the risk of recurrence inclusion criteria of the pivotal [...]
No Comments »
Filed under: Pharmacy News
Posted on February 2nd, 2012 by Health News
The week before and two weeks after surgery are a critical period for the long-term survival rate of cancer patients. Physiological and psychological stresses caused by the surgery itself can inhibit the body’s immune responses, heightening vulnerability to tumor progression and spreading.
No Comments »
Filed under: Pharmacy News
Posted on February 2nd, 2012 by Health News
Long duration, controllable drug delivery is of wide interest to medical researchers and clinicians, particularly those seeking to improve treatment for patients with chronic pain or to prevent cancer recurrence after surgery. Now a team of researchers led by Boston University Biomedical Engineer and Chemist Mark Grinstaff has developed a unique material and drug delivery [...]
No Comments »
Filed under: Pharmacy News
Posted on February 2nd, 2012 by Health News
In patients undergoing hip replacement surgery, using a special wound catheter to infuse local anesthetic directly into the hip joint provides significant and lasting improvements in postoperative pain control, reports a study in the February issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.
No Comments »
Filed under: Pharmacy News
Posted on February 1st, 2012 by Health News
Genentech, a member of the Roche Group, today announced that Erivedge (vismodegib) capsule was approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with a type of skin cancer, called basal cell carcinoma (BCC), that has spread to other parts of the body or that has come back after surgery [...]
No Comments »
Filed under: Pharmacy News
Posted on February 1st, 2012 by Health News
Today, Erivedge (vismodegib) was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. The drug is intended for use in patients with locally advanced basal cell cancer who are not candidates for surgery or radiation and for patients whose cancer has [...]
No Comments »
Filed under: Pharmacy News
